Amselamine

Drug Profile

Amselamine

Latest Information Update: 06 Jul 1998

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Class Heart failure therapies; Small molecules
  • Mechanism of Action Histamine H2 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Heart failure

Most Recent Events

  • 06 Jul 1998 Profile reviewed
  • 06 Jul 1998 No-Development-Reported for Congestive heart failure in Netherlands (Unknown route)
  • 10 Nov 1995 Preclinical development for Congestive heart failure in Netherlands (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top